KVHIKVH Industries, Inc.
KVH Industries, Inc., together with its subsidiaries, designs, develops, manufactures, and markets mobile connectivity and managed services for the marine and land mobile markets. The company offers Internet and VoIP air…
Industry Peers
Telecom Services| Headline | Source | Time |
|---|---|---|
Older | ||
 KVH Industries (KVHI) Q2 2026 Earnings Call Transcript LEO services drove 27% revenue growth as KVH expands maritime connectivity. | ||
 KVH Industries Stock Slips Post Q2 Earnings, Revenues Up on LEO Growth KVHI's LEO transition in second-quarter 2026 gains momentum as Starlink and OneWeb growth boost airtime revenues, while rising costs pressure profitability. | ||
 KVH Industries Q2 Earnings Call Highlights KVH Industries (NASDAQ:KVHI) reported second-quarter revenue growth as demand for low-Earth-orbit, or LEO, connectivity services continued to expand, supported by subscriber additions, Starlink-related sales and new multi-network offerings. Total revenue reached $33.7 million in the second quarter, | ||
 KVH Industries, Inc. Q2 2026 Earnings Call Summary Moby summary of KVH Industries, Inc.'s Q2 2026 earnings call | ||
 KVHI vs. GILT: Which Satellite Communications Stock Is the Better Buy? KVH Industries and Gilat have different markets, growth drivers and valuations, but which satellite communications stock looks better positioned? Let's dive in. | ||
Zacks Initiates Coverage of KVH Industries With Outperform Recommendation Discover why Zacks rates KVH Industries as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore KVHI's transition toward a recurring maritime connectivity platform, fueled by accelerating LEO adoption and subscriber growth. | ||
 The Zacks Analyst Blog Highlights Johnson & Johnson, Lam Research, Seagate, KVH Industries and Dawson Geophysical Johnson & Johnson, Lam Research and Seagate lead today's analyst picks as strong results, AI demand and growth outlooks drive the latest research. | ||
 Top Analyst Reports for Johnson & Johnson, Lam Research & Seagate Johnson & Johnson beat Q2 estimates as growth in key drugs, MedTech and its pipeline helps offset Stelara headwinds. Read what's driving outlook. | ||